Humanigen Inc (fka HGENQ)

[cowtown jay]

I'm glad to see him here, too.

But you know what I don't see? We've got product life cycle management efforts scheduled for next year (New patient segments, label expansion, additional dose formulations), but I don't see any serious commitment to R&D. That may be something Chappell may direct, when they're ready. But the roll-out of our commercialization is going to demand a lot of management's resources in the near term.

Still, though, if I had the education to be able to do R&D in the magical world of mAbs, the allure would compel me to forego other opportunities. It's just a field I think I would be awestruck in love with.

I had the opportunity with Corning Glass Works, after a promotion and transfer to Corning, NY, to have relatively free reign in their Sullivan Park Research Center. I was like a kid in a candy store. I loved it.

Chappell did work in two pioneering research labs. He must miss it.